You are here

Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Postoperative Pain
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Female patients of any ethnic origin aged 18 years or over.

- The patient is post-menopausal, surgically sterile, or using adequate contraception,
not lactating, with a negative urine pregnancy test at screening, prior to
administration of study medication.

- The patient's preoperative health is graded as a class I or II according to the ASA
physical status classification and on the basis of medical history and physical
examination.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- The patient has significant clinical signs and symptoms suggestive of renal or hepatic
morbid conditions

- The patient has a history of clinically significant hypersensitivity to any NSAIDs,
cyclooxygenase inhibitors, analgesics or sulfa medications which has a cross
sensitivity to the medications used in this study.

- The patient used analgesics or other agents (antidepressants, sedating antihistamines
or other sedatives, muscle relaxants, narcotics, or corticosteroids) during the four
hours preceding the procedure that could confound the analgesic responses.

- Subjects with a history of established ischemic heart disease (e.g. myocardial
infarction, stable angina, unstable angina), peripheral arterial disease and/or
cerebrovascular disease (e.g. ischemic or hemorrhagic stroke, transient ischemic
attack), as well as subjects with previous revascularization procedure to coronary,
carotid, cerebral, renal, aortic or peripheral arterial vasculature

NCT00435747
Pfizer
Withdrawn
Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Postoperative Pain, Inguinal Hernia
NCT00551135
Males
17+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now